We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 4.19 | 3.27% | 132.50 | 130.13 | 127.50 | 127.80 | 5,217,690 | 01:00:00 |
From May 2019 to May 2024
The Novo Nordisk AS diabetes drug approved by the FDA is Liraglutide. "FDA Approves Novo Nordisk Diabetes Drug's Use to Fight Obesity," at 4:15 p.m. EST, misstated the name of the drug in the second paragraph.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novo Nordisk Chart |
1 Month Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
